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Emmanuelle Lerat4, Théophile Ohlmann3, Jacques Samarut1*, Anne Mey1*¤
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Biologie Evolutive, Villeurbanne, France
Abstract
The protein of retroviral origin ENS-1/ERNI plays a major role during neural plate development in chick embryos by
controlling the activity of the epigenetic regulator HP1c, but its function in the earlier developmental stages is still
unknown. ENS-1/ERNI promoter activity is down-regulated upon differentiation but the resulting protein expression has
never been examined. In this study, we present the results obtained with custom-made antibodies to gain further insights
into ENS-1 protein expression in Chicken embryonic stem cells (CES) and during their differentiation. First, we show that
ENS-1 controls the activity of HP1c in CES and we examined the context of its interaction with HP1c. By combining
immunofluorescence and western blot analysis we show that ENS-1 is localized in the cytoplasm and in the nucleus, in
agreement with its role on gene’s promoter activity. During differentiation, ENS-1 decreases in the cytoplasm but not in the
nucleus. More precisely, three distinct forms of the ENS-1 protein co-exist in the nucleus and are differently regulated during
differentiation, revealing a new level of control of the protein ENS-1. In silico analysis of the Ens-1 gene copies and the
sequence of their corresponding proteins indicate that this pattern is compatible with at least three potential regulation
mechanisms, each accounting only partially. The results obtained with the anti-ENS-1 antibodies presented here reveal that
the regulation of ENS-1 expression in CES is more complex than expected, providing new tracks to explore the integration
of ENS-1 in CES cells regulatory networks.
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Introduction
Endogenous retroviruses (ERVs) are known to play an
important role in the expression of their host genome, notably
during the first developmental stages when totipotent [1] or
pluripotent cells [2] adopt new cell fates. ERV’s promoters act as
enhancers in different cellular models and lineages [3]. More
rarely, ERVs introduce coding sequences that are adopted by the
host genome to play a major role in host survival. This is the case
for Syncitin, involved in formation of the mammalian placenta [4],
and for ERNI, also called ENS-1 [5], that controls the timing of
the neural plate emergence during chick embryonic development
[6]. More precisely, ENS-1/ERNI acts as a boundary element
between the epigenetic regulator HP1c and the protein complex
that is recruited to the promoter of the neural plate inducer Sox2
before its expression. This linker property involves two distinct
motifs in the protein, the HP1box engaged with HP1c and the
coiled-coil domain interacting with other proteins recruited to the
promoter. The repression, mediated by HP1c, on the promoter of
Sox2 is released in the prospective neural plate due to competition
between ERNI and the newly synthesized protein BERT, another
coiled-coil domain protein that does not bind HP1 [7].
In addition, Erni is expressed earlier during the chick
developmental process notably in the hypoblast, in the pluripotent
epiblast [8] and in its derived embryonic stem cells, cultivated in
vitro [9], where it was called Ens-1. Silencing of the gene occurs
later, as final differentiation is achieved [8,9]. In the epiblast, this
expression pattern is managed by the pluripotency transcription
factor Nanog and by a combination of Gata and Ets transcription
factors that are expressed in the epiblast, in the hypoblast and in
the prospective neural plate [8]. It is probable that the ERV Ens-
1/Erni controls transcription of the host’s genome in pluripotent
cells either directly with its promoter sequences spread over the
genome [5], or indirectly by controlling HP1c on its target genes.
Among them Sox2 is also known as a key-player in the
maintenance of pluripotent cells in mammals [10,11], but other
genes, mainly involved in cell proliferation control, have also been
described in mouse ES cells as HP1c target genes [12].
Despite its important role during chick development, demon-
strated using transient transfections, the expression of the Ens-1
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gene has only been followed at the transcriptional level and the
endogenous protein ENS-1 has never been observed.
In this study, we raised ENS-1 specific antibodies in order to
follow ENS-1 expression in CES cells and during their differen-
tiation. Our results reveal that the distribution of ENS-1 is a new
level of its regulation.
Materials and Methods
Cell culture and DNA transfection
CES are pluripotent stem cells that were isolated from chick
embryonic epiblast [13] and expressing the pluripotency support-
ing genes [14]. CES were cultivated as indicated previously [15].
Plasmid DNA transfections were performed using Lipofectamine
2000 (Invitrogen) in cell cultures at 80% confluency according to
the manufacturer’s instruction. Stable overexpression was ob-
tained using linearized DNA plasmids, and stably transfected cells
were selected by culture in medium supplemented with puromycin
(200 mg/ml). COS7 cells were cultivated with DMEM supple-
mented with 6% fetal calf serum, 1% penicilin/streptomycin, 1%
glutamin.
Antibodies production
The anti-Ens-1 antibody used for immunofluorescence exper-
iments was obtained by immunization of mice with the
recombinant ENS-1 protein produced in Escherichia coli as follow.
The full-length coding sequence of the ENS-1 gene was fused in C-
terminal with a 6x-histidine Epitope tag in a pET-22 expression
system and transformed in Rosetta (DE3)pLys Competent Cells
(Novagen). Protein production was induced with 1 mM IPTG for
3 hours at 37uC and immediately checked by direct loading of
cells on a SDS-polyacrylamide gel followed by Coomassie blue
staining. Cells were then lysed by sonication and the different
fractions (soluble and insoluble cell extracts) were kept for further
analysis. As ENS-1 is predominantly detected in inclusion bodies,
the insoluble fraction was isolated by centrifugation and solubilized
in 8 M urea, 100 mM NaH2PO4, 10 mM Tris HCl (pH 8.0).
ENS-1 His tag protein was purified on Ni-NTA columns (Qiagen)
and refolded by overnight dialysis in 50 mM NaH2PO4, 300 mM
NaCl, 10 mM Tris HCl (pH 8.0). Purification efficiency was
checked by Coomassie blue staining of a SDS-polyacrylamide gel
loaded with the purified ENS-1 protein before its use as
immunogen for antibody production. Production of the monoclo-
nal antibody was carried out by Covalab (France) and immuni-
zations were performed using complete Freund adjuvant accord-
ing to the relevant legislation and following protocols approved by
the ethic committee of the University of Bourgogne (France).
Antibody producing hybridomas were first selected by Covalab for
their reactivity with ENS-1 coated wells in ELISA tests. Positive
hybridomas were next screened for use in western-blotting and in
immunostaining. Their reactivity was tested in CES cells and in
cells devoid of the gene Ens-1 as negative control. The selected
IgG (from clone 16h4g6e4) was purified on protein A-coupled to
Sepharose and called 16h4 in the results part. This unique clone
worked in immunostaining and its specificity is demonstrated in
the results section.
As none of the monoclonal antibodies produced worked in
western-blot, we developed polyclonal antibodies in rabbits using
peptides of 16–20 amino acids isolated from the ENS-1 sequence
as immunogens. Design and purification of the peptides, rabbit
immunizations and antibody purification from the serum were
carried out by Eurogentec using its proprietary adjuvant
combination and following protocols approved by the ethic
committee of the CER groupe (Belgium) according to the
European legislation. One of the three tested peptides (named
3807: C-DRIRVLQNEARTRAGK-CONH2) gave a specific
polyclonal antibody working in western blot as described in the
results section. This antibody did not work in immuno-staining.
The 3807 peptide (DRIRVLQNEARTRAGK) is localized
upstream the coiled-coil domain in the N-terminal part of the
protein and spans amino-acids in position 47 to 62 of the protein
(GenBank: AAK06824.1).
DNA constructs
For transient overexpression experiments, chick HP1c and Ens-
1 (Genbank: NM_001080873) were cloned in a pCi expression
vector (Promega) modified to introduce a FLAG tag at the N-
terminal part of the protein. HP1c (Genbank: NM_204643) was
amplified from chicken ES cDNA. For in vitro translation, Ens-1
was cloned in a pGBKT7 expression vector (Clontech). Genes
expressed in fusion with a GFP protein at their N-terminal part
were cloned in pEGFP-C1 vector (Clontech).
For stable overexpression, Ens-1 was cloned in a bicistronic
construct (pCX Ens-1-HA-ires-puro) to express ENS-1 in fusion
with two HA-tags at the C-terminal part of the protein. In this
construct Ens-1 was separated from the puromycin resistance gene
by an IRES, allowing translation of both proteins from a common
mRNA transcribed under the control of a CAG promoter (a
chicken b-actin promoter combined with a CMV enhancer) to
ensure a strong expression [16].
To test the transcriptional activity of proteins using the CAT
reporter assay, the genes were cloned in the pM vector (Clontech)
to express HP1c or ENS-1 in fusion with a Gal4 DNA binding
domain at their N-terminal part. The reporter plasmid pG4-TK-
CAT (Chloramphenicol Acetyl Transferase) contains six copies of
the Gal4 binding sites upstream of a TK promoter to control CAT
expression. pG4-TK-CAT was a gift from Dr E. Manet and has
been described elsewhere [17]. The renilla luciferase reporter
vector pRL-CMV, used as control, was from Promega.
Targeted mutations of ENS-1 were performed using the Quick
Change Mutagenesis Kit (Stratagene) following the manufacturer’s
instructions. Mutation of the HP1 box (PxVxL) was performed
using the following primers:
Sense:TTGATGAATGGATTAGCCACAGCCAGAGCCGA-
GAAATTAGTTAAC; antisense:GTTAACTAATTTCTCGGC-
TCTGGCTGTGGCTAATCCATTCATCAA. The control mu-
tation was performed on a PxVxL motif that was not involved in the
interaction of ENS-1 with HP1c as assessed using a two-hybrid
assay in yeast described previously [7]. The primers used were:
sense:TTGATGAATGGATTAGCCACAGCCAGAGCCGA-
GAAATTAGTTAAC,
antisense: GTTAACTAATTTCTCGGCTCTGGCTGTGG-
CTAATCCATTCATCAA.
In both PxVxL mutants the proline, valine and leucine amino
acids were replaced by an alanine.
Deletion of the coiled-coil domain from position 238 to position
411 of the Ens-1 coding sequence was obtained by PCR
amplification in two fragments of the sequence flanking the
coiled-coil domain. Primers were designed to introduce an EcoRI
motif that was used to ligate both amplified fragments. The
fragment upstream of the coiled-coil domain was amplified using
the following primers:
sense:ACTCGAGCCACCATGAGCAACAGTATGGCC;
antisense:ACCGGTGTCCTTACACGTGAACTCCACAGC-
TGCTTT. To amplify the fragment downstream of the coiled-coil
domain, the primers were: sense: ACGTGTAAGGACACCGGT;
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antisense: TACGCGTTCAGCTCCCCTTGAGCTT. The dele-
tion of the coiled-coil domain lowers the molecular weight of the
ENS-1 protein by 5.5 kDa.
To measure the activity of both start codons in the ENS1 59
UTR, fragments were cloned downstream to the T7 promoter in
the p0renilla vector previously described [18] as illustrated in the
results. The human b-globin 59-UTR with the authentic initiation
codon was obtained by hybridizing two synthetic oligodeoxyr-
ibonucleotides (Eurogentec) downstream to the T7 promoter to
generate the pGlobin-renilla vector used as control (CTR) [18].
Pull-down experiments
Chicken HP1c cloned in the pCi-flag plasmid was produced in
COS7 cells upon transfection with Exgene 500 (Fermentas)
following the manufacturer’s instructions. The next day, lysis of
COS7 cells was performed (lysis buffer: 50 mM Tris-HCl pH 7.4;
150 mM NaCl; 1 mM EDTA; 1%Triton X-100; 1X Complete
protease inhibitor cocktail (Roche); 1X Halt phosphatase inhibitor
cocktail (Thermo Scientific)), the lysate was centrifuged and the
supernatant was incubated with [35S]-Met (Amersham) to label
ENS-1 synthesized in vitro using a TnT Coupled Reticulocyte
Lysate Systems kit (Promega) and pGBKT7-Ens1 plasmid. The
mixture was incubated for 5 hours at 4uC on a rotating shaker.
The flag-HP1c protein was precipitated using Anti-flag M2 affinity
gel (Sigma) incubated with the protein mixture overnight at 4uC
on a rotating shaker. After centrifugation the agarose beads were
washed four times in washing buffer (50 mM Tris-HCl pH 7.4;
150 mM NaCl). Bound proteins were eluted with loading buffer at
100uC and analyzed by SDS-PAGE and fluorography using a
STORM Phosphorimager.
Immunofluorescence labeling
Cells were seeded on glass cover slides previously coated with
gelatin 1% in 24 wells plates and cultivated to reach 80%
confluency. CES cells were seeded with irradiated feeder cells and
cultivated on the cover slides 48 h before analysis except for
differentiated CES. In this case differentiation was induced 24 h
after seeding without feeder cells, and using 1026M retinoic acid
as previously described [8] for the indicated period of time.
Culture medium was removed and fixation was performed with
2.5% paraformaldehyde in PBS for 20 min at room temperature.
After washing tree times with PBS, the cells were saturated and
permeabilized with saturation buffer (PBS, 0.1% Triton X-100,
10% fetal calf serum). Primary antibodies diluted in saturation
buffer were incubated 1 h at room temperature. After washing
three times with PBS, the secondary antibody diluted in saturation
buffer was added for 1 h at room temperature. Following washing
three times with PBS, cover slides were mounted on a slide using
Gelmount (Biomeda) supplemented with Draq5 (Biostatus) diluted
1/1000. For co-localization studies, cells were incubated with a
mixture of the anti-ENS1 monoclonal antibody 16h4 (5 mg/ml)
produced in mice and the rabbit anti-human HP1c antibody from
Abcam (Ab10480, 1/200). After washing, the cells were incubated
with both Alexa secondary antibodies (1/1000) simultaneously.
F(ab’)2 goat anti-mouse IgG conjugated with Alexa 488 or Alexa
555 or F(ab’)2 goat anti-rabbit IgG conjugated with Alexa 555
were from Molecular Probes. In Fig. S1 immunostaining of CES
was performed using the 42s2 mouse monoclonal antibody
(Upstate) directed against HP1c in addition to the Ab10480
(Abcam).
Acquisition of the images was performed with a Zeiss LSM510
Confocal microscope using a 636 (NA 1.4) Plan NeoFluor
objective (PLATIM, UMS 3444 Biosciences Gerland-Lyon Sud).
Each channel was imaged sequentially using the multi-track
recording module before merging. Experiments were performed at
least three times and gave similar results.
Electron microscopy
CES cells dissociated with trypsin-EDTA (Gibco) were pelleted
by centrifugation and fixed with PFA 4% in PBS for 30 min in ice.
These fixative conditions decreased the detection of the ENS-1
protein observed by immunofluorescence but were required to
preserve most of the cell structures upon the following treatment.
Cells were then washed in PBS, mixed with 1% low melting
point agarose and aspirated into a syringe. After agarose
solidification, cells embedded into agarose were extruded from
the syringe and the resulting extruded rods were cut into 3–5 mm3
cylinders. Samples were washed in PBS at room temperature for
30 min, dehydrated in 70% ethanol and embedded in LR White
resin (Electron Microscopy Sciences). Ultrathin sections were
mounted on nickel grids and immunolabelling performed by
floating the grids onto drops of the different solutions. We used
PBS-1% BSA as saturation buffer. The anti-ENS-1 antibody
(clone 16h4) and the anti-human androgen receptor antibody
(441, Santa Cruz) used as IgG1 negative control were diluted in
saturation buffer and incubated 1 h with the cells. After washing in
PBS the cells were incubated for 1 h at room temperature with
donkey anti-mouse IgG antibody conjugated with 6 nm diameter
gold particles (EM grade, Jackson Immunoresearch) diluted in
saturation buffer. After washing in PBS, the labeling was fixed with
PBS-2% glutaraldehyde for 10 min, washed three times with PBS
and once with water. Ultrathin sections were then contrasted with
uranyl acetate and lead citrate, and examined with a Philips CM
120 electron microscope equipped with a Gatan Orius 200
2Kx2K digital camera (Centre Technique des Microstructures,
Université Lyon 1, Villeurbanne, France).
Protein extractions and western blot
Whole cell lysates were prepared using RIPA lysis buffer (1%
Triton X-100; 0.5% Sodium deoxycholate; 0.1% SDS; 150 mM
NaCl; 0.1 mM DTT; 1 mM EDTA; 1 mM N-ethylmaleimide,
Complete proteases inhibitor (Roche) in Tris-HCl 50 mM,
pH 7.4). Following dissociation using trypsin-EDTA and washing
in PBS, cells were suspended in cold RIPA lysis buffer
(406106 cells/ml) and incubated 30 min in ice. The lysate was
centrifuged at 10000 g for 30 min at 4uC. The supernatant was
harvested and protein concentration was measured using Bradford
reagent (Sigma) and BSA in the standard curve. The indicated
protein quantities were mixed with loading buffer (10% glycerol,
2% SDS, 0.7 M b-mercaptoethanol, 0.01% bromophenol blue in
62.5 mM Tris-HCl pH 6.8) and denaturation was performed
3 min at 100uC.
Fractionation experiments were performed using two protocols.
In the first one, cells were disrupted using detergent before the
cytoplasm and the nucleus were separated. Dissociated cells were
suspended (606106/ml) in cold buffer A (340 mM sucrose,
60 mM KCl, 15 mM NaCl, 2 mM EDTA, 0.5 mM EGTA,
0.1 mM DTT, 0.65 mM spermidine, 0.1% Triton X-100,
Complete EDTA (Roche), 10 mM N-ethylmaleimide in 15 mM
Tris-HCl pH7.4) and incubated 1 min in ice. The cytoplasm and
the nuclei were separated by centrifugation 1500 g for 5 min at
4uC. The cytoplasm corresponding to the supernatant was
clarified from residual nuclei by centrifugation 13000 g at 4uC
for 5 min and the supernatant was harvested (cytoplasmic fraction,
C). The nuclei containing pellets were suspended in buffer A and
washed by deposition on a buffer A cushion in a 14 ml falcon tube
followed by centrifugation at 9400 g for 10 min at 4uC. The nuclei
were disrupted using the hypotonic buffer B (2 mM EDTA,
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0.5 mM EGTA, 0.1 mM DTT, Complete EDTA (Roche),
10 mM N-ethylmaleimide in water). After 30 min incubation in
ice, nuclei disruption was checked using a microscope. Next the
soluble and insoluble nuclei components were separated by
centrifugation 18000 g for 5 min at 4uC. Protein concentration
was measured using Bradford reagent (Sigma) in the cytoplasmic
fraction and in the soluble fraction of the nucleus containing
fractions and the indicated quantities were mixed with protein
loading buffer. The insoluble nucleus fraction was suspended in
buffer A and mixed with the loading buffer (N) without
measurement of the concentration but the volume corresponding
to 66106 cells was loaded to the gel.
In the second fractionation protocol the cells were disrupted
without detergent according to the protocol provided by Abcam
with some modifications. Briefly, cells were dissociated in PBS
using a scraper, rapidly pelleted by centrifugation, re-suspended in
cold fractionation buffer (250 mM sucrose, 20 mM Hepes,
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 1 mM N-ethyl maleimide, Complete protease
inhibitor (Roche)) and passed through a 26G needle before
30 min incubation on ice. Cell disruption was checked using a
microscope. The nuclei were separated from the cytoplasm by
centrifugation 1500 g for 5 min at 4uC. The supernatant
contained the cytosol, the cytoplasmic membrane and mitochon-
dria, the pellet contained nuclei. The supernatant was clarified by
centrifugation 18000 g, 5 min at 4uC to separate the mitochondria
in the pellet from the cytosol and the cytoplasmic membrane in the
supernatant. The cytosol and the cytoplasmic membrane were
separated by ultracentrifugation 100000 g for 1 h at 4uC. The
supernatant corresponding to the cytosol (Cs) was harvested and
the pellet was washed once in the fractionation buffer before
suspension in RIPA lysis buffer (Cp). The nuclei were washed as
indicated in the first protocol on a cushion of fractionation buffer,
suspended in RIPA lysis buffer and sonicated (N).
For protein dosage and loading, all the fractions were treated as
indicated for whole cell lysates.
Proteins separated on 10% SDS-polyacrylamide gels were
transferred on Hybond ECL membranes (GE Healthcare).
Transfer efficiency of the proteins was checked by transient
staining of the membrane using Ponceau’s red (Sigma). Blots were
submitted to Western analysis using the following antibodies: anti-
HP1c (clone 2MOD-1G6AS, Euromedex), anti-HA (HA.7,
Sigma), anti-b tubulin (Sigma), anti-HSP90 (AC88, Enzo), anti-
LaminB1 (Abcam), 2MeH3K4 (Upstate), 3807 anti-ENS-1 poly-
clonal antibody. Anti-mouse and anti-rabbit secondary antibodies
coupled with peroxidase were from Sigma. Saturation of the
membrane was performed in saturation buffer (0.1% Tween, 5%
low fat milk in PBS) 1 h at room temperature. Antibodies were
diluted in saturation buffer and incubated with the membrane at
room temperature for 1 h. After washing 3 times for 10 min in
PBS-0.1% Tween, the membrane was incubated 1 h at room
temperature with the HRP-conjugated secondary antibodies
diluted in saturation buffer. Anti-mouse and anti-rabbit HRP
conjugates were from Promega. After washing, peroxydase activity
was revealed using the Amersham ECL western blotting detection
reagent (GE Healthcare) as substrate and X-ray films (Fuji).
CAT assay
CES cells seeded in 12-well plates were co-transfected at 70%
confluency using Lipofectamine 2000 (Invitrogen) as described by
the manufacturer with a mixture of the following plasmids: pM
plasmid (20 ng) encoding for proteins in fusion with Gal4 DNA
binding domain (GBD-proteins), pG4-TK-CAT reporter plasmid
(300 ng) allowing the tethering of the GBD-proteins upstream the
TK promoter that controls the expression of the CAT gene, pCi
plasmid (200 ng) allowing the expression of additional proteins
and pRL-CMV plasmid (20 ng) as control to normalize transfec-
tion efficiency. After 24 h culture, the medium was removed and
the cells were washed twice with PBS. Cell lysates were prepared
and CAT expression was measured using the CAT ELISA kit
from Roche according to the manufacturer’s instructions. Renilla
luciferase luminescence was measured on templates from the same
lysates using the Renilla Luciferase Assay System (Promega)
according to the manufacturer’s protocol and using a Mithras
LB940 microplate reader (Berthold technologies).
In silico analysis of the Ens-1 gene copies in the chicken
genome
We used the sequence of Soprano [19] as a query to search the
chicken genome (version WASHUC 2, retrieved from Ensembl
http://www.ensembl.org/index.html) using BLASTN [20]. We
recovered 78 copies among which 25 were very conserved
compared to the reference sequence. We used ORF Finder
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html) on the 25 con-
served sequences to determine the presence of ORFs and to
retrieve the subsequent protein sequences. The coiled coil domains
were predicted on the protein sequences using the MultiCoil
program [21].
In vitro transcription
Capped RNAs were obtained by using 2 mg of linear DNA
template mixed with 20 U of T7 RNA polymerase (Promega Co.,
Madison, WI, USA), 40 U of RNAsin (Promega Co, Madison,
WI, USA), 10 mM rATP, rUTP, rCTP, 0.48 mM rGTP, 30 mM
DTT in transcription buffer [40 mM Tris–HCl (pH 7.9), 6 mM
MgCl2, 2 mM spermidine and 10 mM NaCl], the m7GpppG cap
analogue (Invitrogen, Co) was added to a final concentration of
1.92 mM as previously described [22]. The transcription reaction
was carried out at 37uC for 1 h and the RNAs were precipitated
with LiCl at 2.5 M final concentration. The integrity of the RNAs
was checked by electrophoresis on non-denaturating agarose gels
and their concentration was quantified by spectrophotometry at
260 nm using Nanodrop (NanoDrop Technologies, Wilmington,
Delaware, USA).
In vitro translation
In vitro transcribed RNAs were translated in 10 ml of the
supplemented untreated RRL 50% (v/v) (Promega Co., Madison,
WI, USA) in the presence of KCl (75 mM), MgCl2 (0.5 mM),
20 mM of amino acids mix minus methionine and 0.6 mCi of
[35S]-methionine (GE Healthcare Life Sciences) for 30 min at
30uC. Reactions were stopped with 26 SDS-loading buffer and
the products were resolved by 15% SDS–PAGE. Gels were dried
and subjected to autoradiography using Biomax films (Eastman
Kodak Co.).
Results
ENS-1 can control HP1c activity in ES cells
The control exerted by ENS-1 on the transcriptional regulation
mediated by HP1c has been demonstrated in the neural plate [7].
Here we investigated whether this activity might also occur in
chicken ES cells (CES). To this end we used a CAT reporter gene
placed under the control of a minimal VP16 promoter
downstream of the DNA motif recognized by the Gal4 protein.
Cells were co-transfected with a pM vector encoding for HP1c in
fusion with the DNA binding domain of Gal4 (GBD) to target its
interaction with the CAT reporter plasmid. In line with results
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from another study [23], Figure 1A shows that transcription was
repressed when tethering HP1c to the promoter. Transfection of
CES cells with the previous cocktail supplemented with an ENS-1
expression vector restored the transcriptional activity to levels
obtained in the absence of HP1c while ENS-1 mutated in the HP1
box had no effect (Fig. 1A). To test whether ENS-1 acts directly on
the promoter as a transcriptional activator, ENS-1 in fusion with
the GBD was co-transfected with the CAT reporter plasmid.
Transcription was not affected by the recruitment of ENS-1 to the
promoter (Fig. 1B) confirming that the effect of ENS-1 on
transcription was dependent on its interaction with HP1c.
Therefore ENS-1 can directly interact with HP1c and modulate
its function as a transcriptional regulator in CES.
ENS-1 is both a cytoplasmic and nuclear protein
Since HP1c is a nuclear protein, we looked for the distribution
of the endogenous protein ENS-1 in these cells. To this end a
monoclonal antibody was produced against the recombinant
protein ENS-1 (as described in Material and Methods) and tested
for use in confocal microscopy. Among a dozen of clones reacting
with the immunogen, only one was suitable for immunostaining.
Specificity for ENS-1 was first demonstrated by transfection of
CES with the ENS-1-GFP fusion protein. As shown in Figure 2A,
the antibody co-localized with ENS-1-GFP but not with GFP
alone used as control. Secondly, as Ens-1 is restricted to the
galliform species [5], we used STO murine embryonic fibroblasts
as negative control. No signal was observed with the antibody in
these cells (Fig. 2B). Therefore the antibody is specific for ENS-1
and represents a relevant tool to study expression and distribution
of this protein in CES. As shown in Figure 2C almost all the CES
cells expressed ENS-1 but inside the cells the labeling was not
uniform, notably in the cytoplasm when compared with the
nucleus (see Fig. 2D). In the cytoplasm the distribution of ENS-1
appeared as organized, forming a scaffold of spots and stretches
that sometimes crossed-over the nuclear membrane. In the nucleus
that was labelled with Draq5, a stoechiometric DNA-intercaling
agent, the distribution of ENS-1 was more uniform. Nucleolus that
were not labeled with Draq5 were poorly stained with the anti-
ENS-1 antibody (Fig. 2D).
The distribution of ENS-1 was further examined by electron
microscopy with the same antibody (Fig. 3). To preserve the
intracellular structures this approach required fixative conditions
that were stronger than those used for confocal analysis and thus
altered the ENS-1 epitope recognized by the 16h4 antibody. A
compromise was found using 4% PFA only. Most of the cell
structure was preserved as well as the ENS-1 epitope but some
cytoplasmic structures were lost, leaving empty areas in the
cytoplasm that likely correspond to the endoplasmic reticulum
(Fig. 3). ENS-1 was abundantly detected at the periphery of these
areas (Fig. 3A) and in the nucleus (Fig. 3B). Examination of the
cytoplasmic compartment shows that ENS-1 accumulates at the
cytoplasmic membrane (Fig. 3A). In the nucleus, the protein was
found in regions that were more or less dense to electrons, and
corresponding to chromatin and to non-chromatin spaces
respectively, suggesting that ENS-1 location in the nucleus is not
restricted to protein complexes formed on DNA (Fig. 3B). No
particles were observed in controls where anti-ENS-1 antibody
was replaced by an irrelevant antibody (Fig. 3D) or in the absence
of primary antibody (Fig. 3C).
Therefore, we conclude that the protein ENS-1 is expressed in
all CES cells and is largely present in the cytoplasm and in the
nucleus.
ENS-1 sparsely co-localizes with HP1c in the nucleus and
in the cytoplasm
To explore the context in which the interaction between the
endogenous proteins ENS-1 and HP1c may occur, co-localization
experiments were performed in CES. Consistent with a previous
study in mouse ES cells [24], immunostaining of HP1c
heterogeneously formed a speckled and diffuse pattern in the
nucleus of CES (Fig. 4A). Yellow spots in the orthogonal sections
of the cells (Fig. 4B, panel a) indicated that both proteins co-
localized in interphasic nuclei while other ENS-1 and HP1c
molecules were visualized as neighboring green and red spots
respectively. Merging with the DNA staining, in blue, produced
white spots reflecting co-localizations of ENS-1 with HP1c in
chromatin (Fig. 4B, panel b) and a majority of purple spots
corresponding to HP1c on chromatin. These results are in
agreement with the ability of ENS-1/HP1c heterodimers in the
Figure 1. Transcriptional repression by HP1c is modified by its interaction with ENS-1 in CES. CES cells were co-transfected with the pG4-
TK-CAT reporter plasmid and the plasmid encoding for the indicated protein in fusion with a Gal4-DNA binding domain (GBD). An equal amount of
pRL-CMV plasmid encoding for Renilla Luciferase was added to each well for normalization. (A) Transcription inhibition of the CAT reporter gene by
GBD-HP1c in the presence of pCi expression vectors encoding for ENS-1, for ENS-1 mutated in the HP1box. Mutation in an irrelevant PxVxL sequence
was used as control. Maximal inhibition by HP1c was given by co-transfection with the empty pCi vector (Empty). (B) Promoter activity was compared
in the presence of GBD-ENS-1 and GBD-HP1c. In (A) and (B) the promoter activity was assayed by quantifying the amount of CAT protein expressed
by CAT-ELISA. Data were normalized on the basis of the luciferase activity in each well. Results represent CAT expressions in the presence of GBD-
fusion proteins as percent of the maximal expression obtained with GBD alone in the same conditions. They are mean of four (A) and two (B)
independent experiments +/2 SD. Statistics are results of t test relative to the value obtained in the Empty condition: * p,0.005; n.s. not significant
(p.0.1). In (B), CAT activity difference between 2 and 6 ng of GBD-ENS-1 vector is not significant.
doi:10.1371/journal.pone.0092039.g001
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embryo to specifically regulate gene transcription [7]. Panels c, d
and e, showing each of the labeling that were merged in panels a
and b (Fig. 4B), revealed that ENS-1 was present in all the
thickness of the nucleus (panel c) while HP1c and the chromatin
had a more restricted distribution. Notably HP1c proteins were
concentrated in the center of the cells (panel d) while chromatin
was mostly observed in the upper half (panel e). Measurement of
the fluorescence intensity along the longitudinal axis of two cells
confirmed that most of the HP1c dots did not overlap with those
of ENS-1 (Fig. 4C, upper panel) and that co-localization between
both proteins was a restricted event that also occurred in regions
with low DNA density (Fig. 4C, lower panel). These results suggest
that ENS-1/HP1c heterodimers can exist independently on the
interaction with chromatin. In agreement with this hypothesis,
pull-down experiments performed between in vitro translated 35S-
ENS-1 and cell lysates from COS7 cells overexpressing chicken
HP1c demonstrate that the interaction between both proteins is
direct, involving the HP1 box of the ENS-1 protein but not its
coiled-coil domain as illustrated by the use of mutated ENS-1
proteins (Fig.4D). During mitosis, HP1c is released from the
chromatin and is distributed diffusely throughout the cell [25].
Accordingly, in prometaphasic cells when the nuclear membrane
was dissolved, HPc and ENS-1 were progressively released from
the condensing chromatin and accumulated in the cytoplasm
(Fig. 4E). Co-localizations were observed (Fig. 4E panel b) but
most of the proteins were maintained separated as illustrated by
the few number of yellow spots in comparison with the red and
green ones (see panels a and c, Fig. 4E). In interphasic cells some
HP1c molecules were also detected in the cytoplasm as confirmed
Figure 2. Localization of ENS-1 in the cytoplasm and in the nucleus of CES. (A) CES transfected with an expression vector for GFP alone or in
fusion with the ENS1 protein were incubated with the 16h4antibody produced against ENS1. An anti-mouse antibody coupled with Alexa555 was
used as secondary antibody (red) while GFP proteins were in green. Overlapping signals gave a yellow staining. In (B), (C) and (D) immunostaining
with the 16h4 antibody was detected with an Alexa488 anti-mouse antibody (green) and the nucleus was localized by DNA staining with Draq5
(blue). (B) The 16h4 anti-ENS-1 antibody does not label STO murine embryonic fibroblasts (used as negative control). (C) ENS-1 detected in CES cells
cultivated in proliferating conditions. (D) ENS-1 in CES cells at a higher magnification. All observations were performed by confocal microscopy. Is
shown: the signal over the background obtained with the secondary antibodies in the absence of primary antibody. Scale bar 15 mm. The images are
representative of three independent experiments.
doi:10.1371/journal.pone.0092039.g002
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by the use of two distinct antibodies (Fig. S1) and a partial co-
localization with ENS-1 was found in this compartment (Fig. S2 a).
Therefore the interaction between ENS-1 and HP1c does not
require any CES specific co-factor nor chromatin binding and
might occur in the cytoplasm and in the nucleus. However despite
a close contact between both proteins outside the nucleus during
mitosis, the majority of them co-localize in the nucleus of
interphasic cells.
ENS-1 protein is differently regulated in the cytoplasm
and in the nucleus
To better characterize the protein ENS-1 in the cytoplasm and
in the nucleus, we performed western blot analysis of whole cell
lysates. To this end we developed another ENS-1 specific antibody
called 3807 (see Material and Methods). As shown in Figure 5A,
this antibody gave a unique band of about 55 kDa in CES, but not
in mouse ES cells, indicating its specificity for chicken cells. This
molecular weight is in accordance with the 54 kDa prediction
made from the protein sequence (490aa, Genebank: AAK06824).
To confirm that the protein recognized by the 3807 antibody is
ENS-1, CES cells were transfected with an expression vector (pCx
ENS-1-HA-ires-puro) encoding for an HA-tagged ENS-1 protein.
To be sure that antibiotic resistant cells will also express Ens-1
transcripts, both genes were placed under the control of the same
promoter and were separated by an IRES sequence to generate a
unique transcript for both genes that are next translated
independently. Indeed, culture with puromycin of CES cells
transfected with pCx ENS-1 but not with the empty vector,
induced the expression of a unique HA-tagged protein as observed
with the anti-HA antibody in Figure 5B. This protein is also
recognized by the 3807 antibody in addition to the endogenous
ENS-1 protein detected below and in control cells. These results
confirm the specificity of the 3807 antibody for ENS-1.
In a previous report we have shown that the promoter of Ens-1
is repressed while the expression of Sox2 is induced when CES
differentiate [8]. These results are in agreement with the idea that
differentiation of CES in vitro may mimic the release of the
repression mediated by the dimer ENS-1/HP1c on the promoter
of Sox2 before the emergence of the neural plate. To explore the
relevance of this hypothesis, variations of ENS-1 expression during
differentiation were examined at the protein level. Western-blot
results in Figure 5C show that the protein content decreased to
become quite undetectable 24 h after retinoic acid addition and
was maintained at this residual level after 48 h. In the same
samples the expression level of HP1c was not affected by
differentiation (Fig. 5C) in agreement with previous observations
in mouse ES cells [12]. These results are in accordance with the
known regulation of the promoter of Ens-1 [8]. To confirm with
another approach, ENS-1 expression was analyzed during CES
cells differentiation by immunofluorescence experiments using the
16h4 antibody. This approach confirmed the decrease of the
cytoplasmic ENS-1 during differentiation but with changes in the
distribution of ENS-1 (Fig. 6A). In contrast to undifferentiated cells
where the protein was mostly cytoplasmic, the localization was
mostly nuclear in differentiated cells (Fig. 6A, Fig. S2). Notably,
the organized distribution of ENS-1 in the cytoplasm was lost,
giving a diffuse signal after 24 h differentiation that became
undistinguishable from the back-ground after 48 h while the signal
in the nucleus was still over the background (Fig. 6A). These results
suggest that variations in ENS-1 contents are not similar in the
cytoplasm and in the nucleus.
To further explore these changes, enrichments in the nuclear
and in the cytoplasmic proteins were obtained by fractionation of
cell lysates before analysis by western blot using the 3807 antibody.
Results in Figure 6B show that the 55 kDa ENS-1 protein is
present in the cytoplasm and in the nucleus of undifferentiated
cells. However in the nucleus only, this band is flanked by two
other ones of 58 and 47 kDa that were not detected when using
whole cell lysates. During differentiation, the 55 kDa protein was
decreased in the cytoplasm but maintained in the nucleus. This
was also generally true of the two other proteins. More precisely,
the relative proportions of the three ENS-1 related bands in the
nucleus were modified during differentiation. In undifferentiated
Figure 3. Subcellular localization of ENS-1 by electron micros-
copy. CES were labeled with the 16h4 anti-ENS1 antibody. The
secondary antibody was a gold-conjugated anti-mouse antibody (gold
particles are seen as black dots). To preserve the affinity of the antibody
for ENS-1 a moderate fixative procedure (4% PFA) was performed. Some
sub-cellular structures were not well preserved and showed an empty
appearance in the cytoplasm. (A) Observation of ENS-1 close to the
cytoplasmic membrane Cy mb. (a) Magnification of the rectangle
designed in (A).Black arrowheads show the 16h4 dots. (B) Observation
at the junction between the cytoplasm Cy and the nucleus Nu. (b)
Magnification of the rectangle designed in (B) shows ENS-1 in the
chromatin (red arrowheads), in interchromatin spaces (white arrow-
heads) and in the cytoplasm (black arrowheads). (C) No labeling was
obtained in the absence of the 16h4 antibody nor (D) with the anti-
human androgen receptor 441 used as negative control in the same
conditions. (c) and (d) show magnification of the rectangles designed in
(C) and (D) respectively. Non specific dots with the irrelevant primary
antibody in (D) and (d) were larger and have irregular outlines when
compared with the 16h4 antibody (C) and (c).
doi:10.1371/journal.pone.0092039.g003
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cells, the 58 kDa nuclear protein was more abundant than the two
others. After 24 h differentiation, the proportion of the 55 and the
47 kDa bands increased relatively to the 58 kDa band and became
more abundant. Later, in 48h-differentiated cells, all three proteins
were equally and strongly detected in the nucleus (Fig. 6B).
Altogether these results confirm the observations made by
immunostaining with the 16h4 antibody and indicate that the
55 kDa protein ENS-1 is maintained in the nucleus but not in the
cytoplasm upon differentiation. They also reveal that ENS-1-like
Figure 4. Sparse co-localization of ENS-1 and HP1c in CES nuclei. (A) Immunostaining of CES cells was performed simultaneously with the
rabbit anti- HP1c (red) and the mouse anti-ENS-1 antibodies (green) detected using Alexa 555 and Alexa 488 conjugated secondary antibodies
respectively. DNA was stained with Draq5 (blue). Observations were performed by confocal microscopy. (B) Distribution of ENS-1 and HP1c in the
thickness of CES. The z-cut axis is reported in (A) with a yellow bar on the merge panel. Distribution of HP1c and ENS-1 is shown in panel a, co-
localization of both proteins gives a yellow spot. In panel b the DNA staining was shown and white spots indicate ENS-1 and HP1c proteins co-
localizing on DNA. Individual distributions of ENS-1, HP1c and DNA merged in a and b are represented in panels c, d and e respectively. (C)
Fluorescence intensity for the three labels along the line represented in (A) by the white arrow. The upper panel represents fluorescence intensities
obtained for HP1c (red) and ENS-1 (green), the intensities obtained for chromatin (blue) have been added to the lower panel. Arrows point out co-
localizations of HP1c and ENS-1 in or out the chromatin. Intensity axis is in arbitrary units. (D) Pull-down experiments of 35S-ENS-1 with Flag-HP1c.
Lysates from COS cells transfected with pCi-flag- HP1c were used as a source for the flag tagged chicken HP1c protein. 35S labeled ENS-1 proteins
were obtained by in vitro translation from pGBKT7 constructs coding for intact or mutated ENS-1 proteins: del CC indicates deletion of the coiled-coil
domain (-50AA, 5.56 kDa), mutHP1 box indicates mutation in the HP1 box. After incubation of COS7 cell lysates with different dilutions of the ENS-1
proteins, HP1c was precipitated with an anti-flag antibody and the association with 35S-ENS-1 was revealed by fluorography. Representative results of
at least three different experiments. (E) Confocal analysis of a CES cell entering in mitosis (prometaphase) from the same experiment as in A. In panel
a, merge representation of the labeling for ENS-1, HP1c and DNA as in A. In panel (b), fluorescence intensity along the line represented in panel (a) by
the red arrow for the three markers labeled. The panel (c) is a z-cut representation of the same cell.
doi:10.1371/journal.pone.0092039.g004
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proteins recognized by the 3807 antibody are expressed and are
restricted to the nucleus.
It is of note that all these proteins are associated with the
insoluble components of the nucleus (Fig. 6B) and were not found
in the soluble fraction (Fig. S3). The decrease observed in
Figure 5C with whole cell lysates reflects the cytoplasmic ENS-1
protein only since insoluble components were discarded by
centrifugation before analysis.
To confirm that the cytoplasm does not contain the additional
47 and 58 kDa proteins detected in the nucleus, a fractionation
protocol disrupting the cells without detergent was managed to
preserve the soluble and the insoluble parts of the cytoplasm that
were next separated by centrifugation. Results in Figure 6C show
that ENS-1 was restricted to the pellet confirming that ENS-1 is
not a soluble protein. Contamination with nuclear components
was excluded since a unique band of 55 kDa was recognized with
the anti-ENS-1 antibody and only traces of histone (2MeH3K4)
and laminB1 coming from the nucleus were found. In parallel,
analysis of the nuclear content showed the additional bands
already observed with the previous protocol. The homogenous
protein loading rendered possible the quantitative comparisons
between the distinct sub-cellular fractions. The 55 kDa protein
ENS-1 was equivalently distributed between the cytoplasm and the
nucleus in CES cells. In the nucleus only, the 47 kDa was present
but poorly detectable and the abundance of the 58 kDa was
confirmed. Interestingly, HP1c was found in all fractions, in
agreement with immunofluorescence data. Therefore, it seems
that differently from HP1c, ENS-1 is not a free protein in the
cytoplasm nor in the nucleus but is rather associated with insoluble
structures.
Altogether the results obtained by a combination of immuno-
fluorescence and western blot approaches using two distinct ENS-
1 specific antibodies support the conclusion that the endogenous
protein ENS-1 is differently regulated in the cytoplasm and in the
nucleus and that ENS-1-like proteins also contribute to this
difference between both compartments.
In silico analysis of Ens-1 gene copies
Due to its retroviral origin, distinct copies of the gene Ens-1 exist
[5] that may generate distinct ENS-1 like proteins depending on
the conservation of their ORF sequence. Those with the most
conserved ORF in an updated sequence of the chicken genome
are listed in Table 1. Seven copies encode for a 54 kDa ENS-1
protein and one copy for an ENS-1 like protein of 47 kDa but
none for a 58 kDa protein. Based on a full sequence homology
with the 3807 peptide and on conservation of the promoter active
domains [8], the 47 kDa and five of the 54 kDa proteins encoding
copies may account for the protein pattern detected with the 3807
antibody. Copies encoding for lower or for higher molecular
weight proteins ranking from 34 to 69 kDa fulfill the same criteria
but were not detected by this antibody (see Fig.5A, 6C and S3 to
compare distinct cell lysis protocols). Of note, all the ENS-1 like
proteins with an intact 3807 sequence have a conserved coiled-coil
domain but only the 54 kDa proteins have an intact HP1box.
Thus, it can be assumed that ENS-1-like proteins would be
inactive towards HP1c if generated from distinct gene copies.
Alternatively, the 58 kDa ENS-1 like protein may result from
translation initiation starting from a start codon distinct from the
ATG that accounts for the 54 kDa protein. This hypothesis is
supported by the existence of a GTG sequence in the 59UTR of
the gene Ens-1 that is located 96 nucleotides upstream the ATG
(Fig. 7A) and may extend the Ens-1 coding sequence, as already
reported for human genes [26]. Both codons are in frame and the
N-terminal extension generated from the GUG would overweight
the ENS-1 protein of 3 kDa (Fig. 7B), corresponding to the
difference between the 55 and the 58 kDa proteins detected by
western blot. We checked the translation efficiency from the GUG
codon alone or in the presence of the ATG. Using the constructs
containing the 59UTR of ENS-1 upstream of a luciferase reporter
Figure 5. Western blot analysis of the protein ENS-1. (A) Proteins
(15 mg) of whole cell lysates from murine (MES) and chicken (CES) cells
were analyzed by western blot using the anti-ENS-1 3807 antibody.
Protein loading was equivalent in both conditions as illustrated by the
Ponceau’s red staining of the blot. (B) Proteins lysates (20 mg) from CES
cells transfected with an HA-tagged ENS-1 protein (lanes 4,5,6) or with
an empty vector (lanes 1,2,3) were compared with untransfected cells
(WT, lane 7). Triplicates were from three independent transfection
experiments. The HA-tagged protein was detected by the 3807
antibody and by the anti-HA antibody at a molecular weight of
60 kDa. The anti-ENS1 antibody also detected the endogenous protein
at 55 kDa. Both proteins differed in size by 3 kDa corresponding to the
33 additional amino acids added at the C-terminal part of ENS-1 in the
transgenic protein in addition to the two HA tags (2.4 kDa). (C) Western
blot analysis of ENS-1 and HP1c (Chemicon antibody) in whole cell
lysates (12 mg) from undifferentiated CES (-RA) or CES induced to
differentiate with retinoic acid (RA, 1026M) for 4 to 48 h as indicated.
HSP90 was used as protein loading control.
doi:10.1371/journal.pone.0092039.g005
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Figure 6. Subcellular distribution of ENS-1 in CES and during differentiation. (A) Immunostaining of ENS-1 (16h4 antibody) and HP1c
(Abcam antibody) in CES (-RA) and CES differentiated with retinoic acid for the indicated period. Nuclei are labeled with Draq5 and are in blue in
merging panels. Image acquisition was optimized to observe the distribution of the proteins and does not reflect the real expression level. Scale bar
15 mm. (B) Western blot analysis of ENS-1 in the cytoplasmic (Cy) and in the nuclear (Nu) fractions of undifferentiated CES (-RA) or CES induced to
differentiate with retinoic acid for 24h or 48h. Ponceau’s red staining serves as a protein loading control between both fractions. In the nucleus
soluble and insoluble components were separated and only the precipitating fraction that contains ENS-1 is shown. The volume corresponding to
66106 cells was loaded for the N fraction and Lamin B1 was used as loading control. In the cytoplasm (Cy) ENS-1 was in the supernatant, 15 mg of
proteins were loaded and HSP90 was used as loading control. The vertical line indicates missing lanes between the two presented parts of the same
gel. Dotted lines in red indicate the position of three ENS-1 related proteins. (C) Separation of soluble and insoluble components from the cytoplasm.
The cytoplasmic fraction separated from the nucleus was subjected to extended centrifugation. The pellet (Cy p) and the supernatant (Cy s) were
analyzed for ENS-1 protein and HP1c. The nuclear fraction corresponding to the whole nuclear proteins is represented (Nu). Protein loading was
10 mg for each fraction. HSP90 identifies the cytoplasmic soluble fraction, Lamin B1 identifies fractions containing membrane proteins and 2MeH3K4
identifies fractions containing chromatin. Results in (B) and (C) were obtained from two independent experiments using distinct fractionation
protocols. (D) Summary tables of the ENS-1 forms found in the cytoplasm (upper table) and in the nucleus (lower table) from CES cells (-RA) and from
CES induced to differentiate with retinoic for 24 h or 48 h.
doi:10.1371/journal.pone.0092039.g006
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gene under the control of a T7 promoter (Fig. 7C), we generated
RNAs that were used for in vitro translation. Results in Figure 7D
show that the GUG start codon efficiently initiated the translation
of the luciferase gene (as indicated by the arrow (LUC) in lanes II
and I). When the ATG start codon was also present, translation
was initiated from both codons to yield two proteins that differ in
size by 3 kDa. Luciferase was produced from the ATG while the
upstream GTG was responsible for the synthesis of the extended
protein by translation of the 99 nucleotides segment from GTG to
ATG (in lanes IV and III). It is noteworthy that protein expression
from the GTG was less efficient when the latter was placed
upstream of the ATG. Interestingly, when the Ens-1 59UTR was
driving protein synthesis (constructs I and III), expression was
severely reduced from both start codons and translation from
GUG became residual. These data indicate that an N-terminal
extension of ENS-1 during RNA translation may account for the
58 kDa ENS-1 like protein but the low activity of the GUG start in
the context of the Ens-1 59UTR suggests that an additional
regulation of translation would be involved in CES for a real
contribution to the protein pattern revealed with the 3807
antibody.
Finally, it cannot be ruled out that ENS-1 like proteins result
from post-translational modifications of the ENS-1 protein itself.
In yeast two-hybrid assay ENS-1 interacts with the conjugating
enzyme Ubc9 (unpublished data) that transfers a SUMO protein
to its protein substrate [27]. SUMO are about 10 kDa proteins in
size, that is compatible with a modification of the 47 kDa ENS1-
like protein. We found in the sequence of ENS-1 two sumoylation
motifs that are conserved in all the copies with an intact 3807
peptide sequence (Table 2), thus supporting the potential
involvement of post-translational modifications in the production
of the 5 kDa protein. It is of note that one of the SUMO binding
sites is located inside the coiled-coil domain involved in
dimerization of the protein and in its recruitment to Sox2
promoter [7]. In addition, as SUMOylation has been reported to
regulate intracellular distribution of proteins [28], this may explain
the nuclear localization of ENS-1 in spite of lack of nuclear
localization signal.
Table 1. List of the ENS-1 like sequences and homology with the 3807 peptide.
Sequence Position of the gene Protein Size AA Promoter
Name Chrom. Start End Amino Acids (AA) kDa (1) Identity (2) activity (3)
Seq.12 chr1 153080201 153086086 490 54 16/16 Y
Seq.7 chr1 105099609 105104886 490 54 16/16 Y
Seq.32 chr2 95636316 95642444 488 54 16/16 Y
Seq.62 chrUn_ran. 23794802 23799438 487 54 16/16 Y
Seq.10 chr1 146896807 146900813 490 54 16/16 No
Seq.31 chr2 95607871 95610941 427 47 16/16 Y
Seq.38 chr4 29062470 29069620 392 43 16/16 Y
Seq.41 chr5 56151532 56156408 475 52 16/16 Y
Seq.46 chr9 3145510 3148390 627 69 16/16 Y
Seq.52 chrUn_ran. 14717478 14720393 307 34 16/16 Y
Seq.30 (ENS-3) chr2 72991670 73001955 698 77 16/16 Y
Seq.18 chr1 166123942 166128607 490 54 15/16 Y
Seq.2 chr1 49392030 49395290 490 54 15/16 No
Seq.69 chrUn_ran. 48116551 48120222 265 29 15/16 Y
Seq.54 chrUn_ran. 18990010 18992568 160 18 15/16 Y
Seq.15 chr1 164856462 164859682 213 23 N/A Y
Seq.34 chr2 138621760 138623256 210 23 N/A Y
Seq.26 chr2 36219087 36223257 378 42 N/A Y
Seq.24 chr2 11703874 11708540 293 32 N/A Y
Seq.40 chr5 3991240 3997526 182 20 N/A Y
Seq.8 chr1 134745214 134749487 182 20 N/A Y
Seq.22 chr12 18117921 18121939 182 20 N/A Y
Seq.35 chr3 92605110 92611133 182 20 N/A Y
Seq.20 chr1 167194063 167197535 182 20 N/A No
Seq.3 chr1 49395084 49396779 ,10 N/A N/A Y
Among 78 copies detected in the chicken genome, 25 were very conserved compared to the reference sequence and are listed below. ORF Finder was used to
determine the presence of ORF and to retrieve the subsequent protein sequence. Identity with the 3807 peptide (16 amino acids) defined three categories: total identity
(16/16 AA), partial identity (15/16 AA) or no identity (N/A).
(1) The molecular weight of the protein was calculated with the formula: AA number X 110/1000.
In bold are indicated the protein sizes detected in CES cell lysates with the 3807 antibody in western-blotting.
(2) Identity between the ENS-1 like protein sequences and the 3807 peptide (DRIRVLQNEARTRAGK)
(3) Potential activity based on the presence (Y) or the absence (No) of the Nanog, Gata and Ets transcription factors binding sites controling promoter activity.
doi:10.1371/journal.pone.0092039.t001
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Discussion
This paper describes the endogenous form of the protein ENS-1
that controls the timing of the neural plate emergence in chicken
by interacting with the epigenetic regulator HP1c. Using different
approaches, based on new antibodies raised against ENS-1, we
show that this protein is strongly expressed in pluripotent CES
cells isolated from the epiblast, in agreement with its transcrip-
tional pattern of expression [8]. These antibodies are specific for
ENS-1 since they react with a tagged-ENS-1 transgene but not
with cells devoid of the Ens-1 gene. Each antibody was screened
for immunofluorescence and for western-blot applications but
none worked in both approaches. Therefore both antibodies were
used in parallel in western blot or in immunofluorescence to
characterize the protein ENS-1. They gave converging results
about localization of the protein both in the nucleus where HP1c
Figure 7. Presence of two start codons in the Ens-1 59UTR. (A) The region containing the two putative start codons in the sequence encoding
the whole mRNA (NM_001080873) is represented. The ATG start codon (in red) is the authentic initiation site and generates the 54 kDa protein that
has been published previously (NM_001080873.1). The GTG codon (in red) is positioned 96 nucleotides. upstream of the AUG and generates a 57 kDa
protein. The purine in positions -3 or +4 from the first base of each start codon is squared (Kozak consensus sequence). (B) Putative sequence of both
proteins that only differ by the 3 kDa peptide in N-terminal position represented in bold. (C) Schematic representation of the constructs used to
validate the translation initiation from the GTG and the ATG start codons in the 59 UTR of Ens-1. (D) RNA generated from the constructs depicted in
(C) were used for in vitro translation of the luciferase protein in the presence of radioactive methionine. [35S]methionine-labelled proteins were
separated on SDS-PAGE and revealed by autoradiography. The position of the luciferase protein (LUC) generated by constructs with only one start
codon is indicated (GTG in Ens-1 59UTR or ATG in CTR). Initiation from the two start codons generates LUC with ATG and a larger protein (LUC+3 kDa)
resulting from initiation at the upstream GTG.
doi:10.1371/journal.pone.0092039.g007
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is concentrated and in the cytoplasm, but with distinct features as
revealed by western blot. In the nucleus, but not in the cytoplasm,
three anti-ENS-1 reactive bands were found. Our results support
the idea that the relative proportion of these ENS-1 like proteins is
part of the regulation of ENS-1.
Indeed, differentiation of ES cells using retinoic acid promotes
their commitment preferentially toward the neurectoderm [12].
Under these conditions, the expression of ENS-1 at the
transcriptional level is only partially repressed [8]. With both
antibodies we show in parallel, that the ENS-1 protein content is
decreased in the cytoplasm but not in the nucleus where it is
maintained but with deep changes in the relative proportions of all
three proteins.
In the prospective neural plate the recruitment of ENS-1 to the
promoter of Sox2 represses the gene, and activation [29] [30] is
induced by competition with the neo-synthesized protein BERT
that releases ENS-1 [7]. In mice, Sox2 [31] is known to be, along
with Oct4 [32] and Nanog [33], one of the key players of
pluripotency that are repressed during differentiation. Differently,
in CES cells we reported that Sox2 is induced upon differentiation
[8], suggesting that ENS-1 is fully active to repress Sox2 in CES.
In agreement, we show here that ENS-1 can control the function
of HP1c in a reporter system and that both proteins locally co-
localize on chromatin in the nucleus of CES cells.
Identification of genes targeted by the ENS-1/HP1c heterodi-
mer in CES represents a future challenge to understand
integration of these proteins in the pluripotency network of CES
cells, and the data presented here strongly support the develop-
ment of approaches directly addressing this question at the protein
level. The development of additional antibodies suitable for
immune-precipitation will be required, this cannot be achieved
with the antibodies presented here. Targeting other epitopes of the
protein for antibody preparation will also be essential to better
characterize the nature of the ENS-1 like proteins. The analysis of
the different Ens-1 gene sequences suggests that distinct copies of
the gene Ens-1 or another translation initiation start could at least
partially explain the ENS-1 protein pattern observed, but the
contribution of post-translational modifications cannot be exclud-
ed.
Table 2. Conservation of functional domains in ENS-1 like copies.
Protein size Domains conservation and their position (AA)
kDa HP1box (1) cc-domain (2) Sumo site 1 (3) Sumo site 2 (4)
Sop.12 54 469 92-126 180 96
Sop.7 54 469 92-126 180 96
Sop.32 54 467 92-124 178 96
Sop.62 54 466 92-123 177 93
Sop.10 54 469 92-126 180 96
Sop.31 47 / 109-144 198 114
Sop.38 43 / 96-123 180 96
Sop.41 52 / 92-126 180 96
Sop.46 69 / 92-126 180 96
Sop.52 34 / 95-123 180 96
Sop.30 ( = ENS-3) 77 / 422-450 507 423
Sop.18 54 469 92-126 180 96
Sop.2 54 469 92-126 180 96
Sop.69 29 / 92-124 180 96
Sop.54 18 / 85-124 / 92
Sop.15 23 / / 36 /
Sop.34 23 / / 77 /
Sop.26 42 357 / 68 /
Sop.24 32 272 / / /
Sop.40 20 161 / / /
Sop.8 20 161 / / /
Sop.22 20 161 / / /
Sop.35 20 161 / / /
Sop.20 20 161 / / /
Sop.3 N/A 113 / / /
In red are indicated the copies with an intact 3807 sequence and with an intact promoter.
(1) Based on the HP1 box motif involved in the interaction of ENS-1 with HP1c: GLPTVRLE.
(2) Coiled-coil(cc) domain defined using the MultiCoil program.
(3) Sequence motif PLIKTEY.
(4) Sequence motif ESVKVTQ, inside the coiled-coil domain.
doi:10.1371/journal.pone.0092039.t002
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In conclusion our results demonstrate that understanding the
regulation of the protein ENS-1 is more complex than could be
anticipated from analysis of its transcripts and this study provides
new tools to track this important protein during chick develop-
ment.
Supporting Information
Figure S1 Immunostaining of the chicken HP1c with the
commercial antibody. (A) CES cells transiently transfected
with HP1c in fusion with GFP (green) were labeled with the
Ab1080 (Abcam) antibody used in Fig. 4. (B) CES cells were
labeled with a mixture of the rabbit Ab1080 (red) and the mouse
42s2 (green, Upstate) anti- HP1c antibody. The secondary
antibodies used were an anti-rabbit conjugated with Alexa 555
(red) and an anti-mouse antibody conjugated with Alexa 488
(green). Overlapping signals gave a yellow color. Results from two
independent experiments are presented. In the nucleus both
antibodies gave similar staining and both detected traces of HP1c
in the cytoplasm but with more or less intensity depending on the
experiment.
(TIF)
Figure S2 Distribution and colocalization of ENS-1 with
HP1c during differentiation of CES cells. Images are those
presented in Figure 5C complemented with fluorescence intensity
for the three labeling along the line represented in the merged
image by the red arrow. CES cells (a) or cells differentiated for 4 h
(b), 24 h (b) or 48 h (d) with retinoic acid were stained as in
Figure 4 with anti-ENS-1 (green) and anti-HP1c antibody (red).
Signal intensities are presented as arbitrary units.
(TIF)
Figure S3 Western blot of soluble and insoluble protein
fractions in the nucleus of CES cells. The whole blot
corresponding to Fig. 5D is represented. N1 to N3 and S1 to S3
are loading replicates of respectively the insoluble and the soluble
fractions of the nucleus. The S fractions had proteins concentra-
tions lower (5 mg) than the N fractions (15 mg) but even in the S3
fraction that was slightly colored by Ponceau’s red, no ENS-1
protein was detected.
(TIF)
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